Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Use of metabotropic glutamate receptor potentiators discussed by Lilly

Sep. 19, 2001

Levodopa with physiotherapy may improve motor recovery in stroke

Sep. 19, 2001

Synthetic peptide-based treatment for MS completes phase II trial in Canada

Sep. 19, 2001

Solvay identifies new atypical antipsychotic candidate

Sep. 18, 2001

Enrollment completed in pivotal Alzheimer's disease trial of Neotrofin

Sep. 17, 2001

Subtype-selective nAChR ligands designed at British university

Sep. 14, 2001

Evidence presented in Nice supports lavender aromatherapy in dementia-associated agitation

Sep. 14, 2001

Increase in ACh efflux may underlie cognition-improving effects of atypical antipsychotics

Sep. 14, 2001

Intercalating agent may be useful in MS; preclinical data presented at ECTRIMS 2001

Sep. 14, 2001

Novel chelator designed by D-Pharm commences phase II clinical development for stroke

Sep. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...